Today: 25 June 2026

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Construction Partners stock rises after outlook hike, DA Davidson lifts target to $130

Construction Partners stock rises after outlook hike, DA Davidson lifts target to $130

Construction Partners shares rose 1.2% to $129.13 Friday after DA Davidson raised its price target to $130. The move followed a quarterly report showing net income of $17.2 million, revenue of $809.5 million, and a record $3.09 billion backlog. The company lifted its 2026 revenue outlook to as high as $3.56 billion. Granite Construction and Sterling Infrastructure shares also gained.
6 February 2026
Tapestry stock rises again as Coach Tabby bags fuel forecast hike — what TPR investors watch next

Tapestry stock rises again as Coach Tabby bags fuel forecast hike — what TPR investors watch next

Tapestry shares rose 3% to $147.51 Friday morning after the company raised its annual outlook, citing strong Coach sales. Coach revenue jumped 25% to $2.14 billion in the holiday quarter, while Kate Spade sales fell 14%. Tariffs cut about 190 basis points from gross margin. Tapestry set a quarterly dividend of $0.40 per share, payable March 23 to holders as of March 6.
6 February 2026
Ensign Group stock climbs toward $200 after 2026 outlook; Truist lifts ENSG target

Ensign Group stock climbs toward $200 after 2026 outlook; Truist lifts ENSG target

Ensign Group shares rose 1.4% to $199.86 in early Friday trading after the company projected 2026 diluted EPS of $7.41–$7.61 and revenue of $5.77–$5.84 billion. Truist raised its price target to $215, citing improved occupancy and acquisitions. Ensign reported Q4 revenue of $1.36 billion and net income of $95.5 million. The company ended 2025 with 378 operations and $503.9 million in cash.
6 February 2026
Corpay stock edges higher today as CPAY earnings, PayByPhone sale and broker targets keep bulls engaged

Corpay stock edges higher today as CPAY earnings, PayByPhone sale and broker targets keep bulls engaged

Corpay shares rose 1.4% to $339.73 Friday after the company posted fourth-quarter revenue of $1.25 billion, up 21%, and issued strong 2026 guidance. The company plans to sell its PayByPhone unit and now expects 2026 revenue between $5.215 billion and $5.315 billion. Analyst price targets increased following the report. Corpay’s corporate payments division saw a 39% revenue jump to $480.8 million.
6 February 2026
Kodiak Gas Services stock jumps on $675 million DPS buy as data-center power demand bites

Kodiak Gas Services stock jumps on $675 million DPS buy as data-center power demand bites

Kodiak Gas Services shares rose 4.2% to $49.29 after announcing a $675 million acquisition of Distributed Power Solutions, funded by $575 million in cash and $100 million in stock. The deal, expected to close in early Q2 2026, awaits antitrust approval and hinges on Kodiak maintaining leverage targets. Investors await further details at the Feb. 26 earnings call.
Regal Rexnord stock ticks higher after $735 million data-center orders put 2026 outlook in play

Regal Rexnord stock ticks higher after $735 million data-center orders put 2026 outlook in play

Regal Rexnord shares rose 1.4% to $202.75 Friday after posting fourth-quarter adjusted earnings of $2.51 per share and 2026 guidance of $10.20–$11.00 EPS. The company reported $735 million in E-Pod orders tied to data-center power projects, with first shipments expected in 2027. Revenue for the quarter was about $1.52 billion. Management flagged weak residential HVAC demand and uncertainty in converting backlog to revenue.
Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

Kulicke & Soffa stock price today: KLIC steadies premarket after 19% earnings jump, Needham lifts target

Kulicke & Soffa shares rose 0.4% to $66.66 in premarket trading Friday after a 19.3% surge Thursday, following upbeat Q2 revenue guidance of around $230 million. Fiscal Q1 net revenue reached $199.6 million, with utilization rates topping 80% in general semiconductors. Needham raised its price target to $70. The company filed its latest 10-Q on Thursday.
FormFactor stock holds near $84 after earnings beat — what FORM investors watch next

FormFactor stock holds near $84 after earnings beat — what FORM investors watch next

FormFactor shares were flat in premarket trading Friday after a 17% jump on Thursday, closing at $83.87. The company posted record quarterly revenue of $215.2 million and GAAP net income of $23.2 million. Management raised guidance for the March quarter and set May 11 as its next Analyst Day. CFO Aric McKinnis said margin gains outpaced expectations but warned tariffs continue to weigh on results.
6 February 2026
SiTime stock jumps premarket as $3.2 billion Renesas timing deal keeps SITM in play

SiTime stock jumps premarket as $3.2 billion Renesas timing deal keeps SITM in play

SiTime shares rose 3.3% in premarket trading Friday after announcing a $1.5 billion cash-and-stock deal to acquire Renesas’ timing business. The company reported $113.3 million in fourth-quarter revenue, up 66% year-over-year, and issued a positive forecast for the first quarter. SiTime expects the acquired unit to add $300 million in revenue within a year of closing.
AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD stock rebounds before the bell after brutal selloff as China supply worries surface

AMD shares rose about 4% in premarket trading Friday, rebounding after a two-day slide erased over 20% of its value. The company forecast Q1 revenue near $9.8 billion, about 5% below the previous quarter, and warned Chinese clients of server CPU supply delays. AMD’s stock hovered near $200 after closing at $192.50 Thursday. Uncertainty remains over U.S. export licenses for China-bound AI chips.
6 February 2026
Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco shares slide as Banco Bradesco maps 2026 growth after Q4 profit

Bradesco’s preferred shares fell 4.5% to 20.19 reais in Sao Paulo after the bank posted a fourth-quarter recurring net income of 6.5 billion reais and outlined 2026 growth targets. The bank expects loan growth of 8.5%–10.5% and net interest income after provisions of up to 48 billion reais. Investors are watching credit costs and expenses linked to Bradesco’s ongoing restructuring.
6 February 2026
CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions stock price whipsaws: premarket bounce follows 13% slide as GM lawsuit surfaces

CCC Intelligent Solutions shares rose 1.2% to $5.75 in premarket trading Friday after plunging 12.6% the previous session. Court records show General Motors sued CCC and others in a U.S. design-patent case. CCC also announced expanded access to its estimating software for collision-repair schools following a new workforce study. Quarterly results are due Feb. 24.
6 February 2026
Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer stock slips before open as TrumpRx discounts debut and FDA priority review adds a catalyst

Pfizer shares fell 1.1% to $26.49 in premarket trading after the TrumpRx discount drug portal launched Thursday, raising concerns over U.S. drug pricing. Pfizer said its TrumpRx program offers discounts of up to 85% on more than 30 medicines. The FDA granted Priority Review for expanding Hympavzi use in younger hemophilia patients, with a decision expected in the second quarter.
BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion (BMNR) stock bounces premarket after Thursday rout as ether trades below $2,000

BitMine Immersion shares rose 8.7% to $18.91 in premarket trading Friday after plunging 14.3% the previous session. Ether dropped nearly 5%, settling near $1,955, while Bitcoin hovered around $67,421. Crypto-linked stocks including Coinbase and Marathon Digital also fell sharply before the open. BitMine holds over 4.2 million ether tokens and plans to launch its MAVAN staking network by Q1 2026.
6 February 2026
1 68 69 70 71 72 595

Stock Market Today

  • Temple & Webster Shares Jump 5.59% on ASX Amid Controlled Trading
    June 25, 2026, 11:24 AM EDT. Temple & Webster Group Ltd (ASX:TPW) shares rose 5.59% to AUD 6.04, within an intraday range of AUD 5.76 to AUD 6.07, signaling positive market sentiment. Despite a trading volume of 936,738 shares below the average 1.34 million, the stock showed balanced buying and selling interest on the ASX. The company's market capitalisation stands near AUD 666.64 million. TPW operates in the online homewares and furniture retail segment, sensitive to consumer discretionary trends and housing demand cycles. The 52-week price fluctuated significantly between AUD 4.53 and AUD 29.06, highlighting volatility over the past year. The session's narrow price range suggested a consolidation phase following prior price moves, with cautious market participation.

Latest News

US stocks now: Broad gains balance $416 billion drop in megacap tech

US stocks now: Broad gains balance $416 billion drop in megacap tech

25 June 2026
Apple, Nvidia, Microsoft, Alphabet, and Meta lost about $416 billion in combined market value as investors rotated into Dow and small-cap stocks, with Apple dragging after raising MacBook and iPad prices due to higher memory costs; meanwhile, Micron surged 10.4% on strong earnings and guidance, and Qualcomm gained 3.6% after boosting long-term revenue targets.
Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

25 June 2026
Bio-Techne surged 19% to $70.17 after Merck KGaA’s $73 per share cash offer, leaving a $2.83 spread as the deal awaits shareholder and regulatory approval, with closing expected in late 2026 or early 2027; trading volume soared past short interest, and the deal values Bio-Techne at $11.3 billion, less than 9.4 times fiscal 2025 sales.
Go toTop